It has been demonstrated to activate AMP-activated protein kinase (AMPK), a critical regulator of energy metabolism that promotes fatty acid oxidation and inhibits lipogenesis in the liver
GLP-1: The Appetite Brake GLP-1 (glucagon-like peptide-1) signals to your brain that youre full
The tirzepatide group experienced a mean weight loss of 15% from the baseline, compared to a 3% loss in the placebo group
Krishnan A, Woreta TA, Sims OT, Hamilton JP, Potter JJ, Alqahtani SA (2023) Impact of nonalcoholic fatty liver disease on clinical outcomes in patients with COVID-19 among persons living with HIV: a multicenter research network study
### AOD-9604 Mechanism of Action AOD-9604 is believed to promote **fat loss** through: - Stimulation of lipolysis in adipose tissue via beta-3 adrenergic receptor pathways - Inhibition of lipogenesis (new fat formation) - No effect on growth hormone receptors (does not promote tissue growth) - No effect on IGF-1 levels or blood glucose Importantly, AOD-9604 does **not** suppress appetite or affect food intake it is purely a lipolytic **fat loss peptide**
